Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article matching "inflammation"

ResearchCLINICALTRIALSMay 7

Trial Completed: Gait in Rare Diseases (NCT05161494)

Researchers completed a study looking at whether treatments that help with walking problems in one rare genetic disorder (Dravet Syndrome) could also help people with two other rare genetic disorders: Tuberous Sclerosis Complex and STXBP1 Encephalopathy. The study enrolled 41 people total and aimed to see if the same approach to treating movement and walking difficulties caused by epilepsy and developmental delays could work across different genetic conditions.

WHY IT MATTERSIf successful, this research could lead to new treatment strategies for gait and movement problems in Tuberous Sclerosis Complex and STXBP1 Encephalopathy—conditions where walking difficulties significantly impact quality of life but have limited treatment options.
Good to knowTuberous Sclerosis ComplexSTXBP1 Encephalopathy With EpilepsyDravet Syndrome

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases